US Stock MarketDetailed Quotes

LIANY LianBio

Watchlist
  • 0.236
  • +0.002+0.81%
15min DelayClose Jan 21 16:00 ET
25.48MMarket Cap-0.29P/E (TTM)

About LianBio Company

LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.

Company Profile

SymbolLIANY
Company NameLianBio
Listing DateNov 1, 2021
Issue Price16.00
Founded2019
CEOMr. Adam Stone
MarketPink Market
Employees52
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address103 Carnegie Center Drive,Suite 309
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-609-486-2308

Company Executives

  • Name
  • Position
  • Salary
  • Adam Stone
  • Director and Interim Chief Executive Officer
  • --
  • Ehong Gu
  • Interim Chief Financial Officer and Vice President, Head of Global Finance
  • --
  • Brianne Jahn
  • Chief Business Officer
  • --
  • Pascal Qian
  • General Manager, China and Senior Vice President
  • --
  • Konstantin Poukalov
  • Executive Chairman of the Board
  • --
  • Neil Kumar, PhD
  • Director
  • --
  • Susan Silbermann
  • Independent Director
  • --
  • Wei Wei Chen
  • Independent Director
  • --
  • Tassos Gianakakos
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.